The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(3-(diethylamino)propyl)-2-(6H-indolo[2,3-b]quinoxalin-6-yl)acetamide ID: ALA4082211
PubChem CID: 12323203
Max Phase: Preclinical
Molecular Formula: C23H27N5O
Molecular Weight: 389.50
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCN(CC)CCCNC(=O)Cn1c2ccccc2c2nc3ccccc3nc21
Standard InChI: InChI=1S/C23H27N5O/c1-3-27(4-2)15-9-14-24-21(29)16-28-20-13-8-5-10-17(20)22-23(28)26-19-12-7-6-11-18(19)25-22/h5-8,10-13H,3-4,9,14-16H2,1-2H3,(H,24,29)
Standard InChI Key: HUTGXVVUKKGFCG-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
22.1824 -9.3770 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1813 -10.1966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8893 -10.6055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8875 -8.9682 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5962 -9.3734 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5969 -10.1924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3055 -10.5995 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.2999 -8.9632 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.0090 -9.3666 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0166 -10.1856 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7980 -10.4315 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.7856 -9.1063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2711 -9.7646 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0819 -9.6725 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4084 -8.9228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9179 -8.2644 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.1088 -8.3597 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0585 -11.2061 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5180 -11.8190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7785 -12.5935 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.7169 -11.6573 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.2380 -13.2064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4985 -13.9810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9580 -14.5939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1569 -14.4322 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.6164 -15.0451 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8964 -13.6576 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8153 -14.8834 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0954 -13.4960 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 10 2 0
9 8 2 0
8 5 1 0
9 10 1 0
10 11 1 0
11 13 1 0
12 9 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
11 18 1 0
18 19 1 0
19 20 1 0
19 21 2 0
20 22 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
25 27 1 0
26 28 1 0
27 29 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 389.50Molecular Weight (Monoisotopic): 389.2216AlogP: 3.59#Rotatable Bonds: 8Polar Surface Area: 63.05Molecular Species: BASEHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 9.84CX LogP: 3.08CX LogD: 0.68Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.47Np Likeness Score: -1.47
References 1. Klimenko K, Lyakhov S, Shibinskaya M, Karpenko A, Marcou G, Horvath D, Zenkova M, Goncharova E, Amirkhanov R, Krysko A, Andronati S, Levandovskiy I, Polishchuk P, Kuz'min V, Varnek A.. (2017) Virtual screening, synthesis and biological evaluation of DNA intercalating antiviral agents., 27 (16): [PMID:28666733 ] [10.1016/j.bmcl.2017.06.035 ]